openPR Logo
Press release

Ventricular Assist Devices Market 2019 Demand, Size, Growth Research Report by 2025

01-14-2020 05:27 PM CET | Health & Medicine

Press release from: Global Market Insight, Inc

Ventricular Assist Devices Market

Ventricular Assist Devices Market

Global Ventricular Assist Devices Market value over USD 3.5 Billion by 2025 end and register a CAGR of over 6.3% from 2019 to 2025.

U.S. Ventricular Assist Devices market | Impact of growing cardiovascular diseases on the regional industry growth:

The United States Ventricular Assist Devices market is touted to be largely driven by the growing number of cardiovascular disease CVD cases across the nation. According to a 2018 report by the American Heart Association, approximately 92.1 million adults across the U.S. are suffering from some form of CVD or the after-effects of a stroke. Around 2,300 Americans lose their lives to CVDs every day – an average one death every 38 seconds. The U.S. Centers for Disease Control & Prevention (CDC) lists high cholesterol, high blood pressure and smoking as the key risk factors leading to heart diseases, further specifying that approximately 47% of Americans are suffering from at least one of the three listed risk factors.

Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/3014

Ventricular Assist Devices market report provides a comprehensive landscape of the industry, accurate market estimates and forecast split by product, application, technology, region and end-use. All quantitative information is covered on a regional as well as country basis. The report provides valuable strategic insights on the Ventricular Assist Devices market, analyzing in detail industry impact forces including growth drivers, pitfalls and regulation evolution. The report also includes a detailed outlook on the Ventricular Assist Devices market competitive environment, diving into the industry position of each major company along with the strategic landscape.

These conditions coupled with recent technological advancements across the nation as well as favorable reimbursement policies would be some of the major influencing parameters fueling the growth of the U.S. Ventricular Assist Devices market. As a matter of fact, the U.S. Ventricular Assist Devices industry size is projected to register a modest CAGR of 9.8% over 2018-2024.

Driven by a spate of technological advancements in the domain of medical equipment, Ventricular Assist Devices market has come up to be one of the most lucrative verticals of the healthcare space. A VENTRICULAR ASSIST DEVICES is essentially a medical device that is used to help with the heart functions & blood flow in patients with failing or weak hearts. Technological developments of late are making Ventricular Assist Devices less invasive, more risk-free and efficient, fueling a significant increase in their adoption rate, further advancing Ventricular Assist Devices industry growth. These technological enhancements coupled with constantly improving implementation procedures have successfully reduced the associated health risks while also ensuring an increased survival rate in patients.

The global Ventricular Assist Devices market is also expected to accumulate significant proceeds on account of the growing obese and geriatric population worldwide, a demographic most likely to experience heart problems & heart diseases. According to the World Health Organisation (WHO), a survey in 2016 discovered that over 1.9 billion adults, above 18 years of age, were overweight with approximately 650 million of them being obese. Meanwhile, a report from the United Nations predicts the global geriatric population to more than double by 2050. These factors are quite overtly, compelling further innovations in the healthcare industry, expediting Ventricular Assist Devices market trends.

Left Ventricular Assist Devices market | To be propelled by the lack of heart donors
Left Ventricular Assist Devices are increasingly becoming a prevalent treatment options for individuals suffering from Stage-D heart failure with a reduced ejection fraction. According to a report published on the Journal of the American College of Cardiology (JACC), owing to technological advancements, the devices are becoming more durable and reliable, significantly extending the prospects of survival in patients suffering from the ailments. Although there are adverse effects, the device greatly improves the quality of life, claim medical experts.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3014

Nonetheless, with an ongoing organ donor shortage experienced for cardiac transplantation, the Left Ventricular Assist Devices are increasingly becoming the go-to substitute for a full-fledged transplant, especially in elderly patients. Attributing to these inducing factors, the left Ventricular Assist Devices market is projected to record a CAGR of about 10.6% over 2018-2024.

The populous Indian sub-continent is anticipated to crop up as another remunerative revenue pocket for Ventricular Assist Devices market. Quite overtly, the growth across the country is powered by the extensive prevalence of cardiovascular disorders in the region. A report presented in the AHA Journals in 2016 claimed that premature mortality (in terms of years of life lost) on account of CVD in India surged by 59% – from 23.2 million in 1990 to 37 million in 2010. Even the World Health Organization declared that cardiovascular diseases are one of the major factors contributing to the cases of mortality across the region, that would quite overtly push the India Ventricular Assist Devices market size in the years to come.

The positive growth graph of India Ventricular Assist Devices industry can also be attributed to the nation’s expanding medical tourism industry, that stems from the significantly cheaper cost of medical treatment in the country. While a LVENTRICULAR ASSIST DEVICES procedure costs approximately $175,400 in the U.S., the same procedure costs approximately $12,600 in a hospital in India that provides superlative medical treatment from skilled doctors. According to IMS Health & FICCI, India accounts for about 18% of the world’s medical tourism market. In the decades to come, medical tourism is touted to emerge as a major factor propelling the India Ventricular Assist Devices industry growth.

Browse Report Summary @ https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market

Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Ventricular Assist Devices industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Age group trends
2.1.5. Regional trends
Chapter 3. Ventricular Assist Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increase in number of heart failures and cardiovascular diseases in Europe
3.3.1.2. Technological advancements in North America
3.3.1.3. Growing geriatric population in Asia Pacific
3.3.1.4. Rise in awareness regarding heart failure treatment in Latin America
3.3.1.5. Decrease in number of heart donors across the globe
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of the device and procedure
3.3.2.2. High health risk associated with product and procedures
3.3.2.3. Stringent regulatory regulations
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By application
3.4.3. By age group
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.6. Technology landscape
3.7. Left Ventricular Assist Devices properties
3.8. Global prevalence of cardiovascular diseases, 2017
3.9. Global heart transplantation scenario
3.10. Porter’s analysis
3.11. Competitive landscape, 2017
3.11.1. Business overview
3.11.2. Revenue analysis
3.11.3. Product landscape
3.11.4. Strategy dashboard
3.12. PESTEL analysis

More Insightful Info: https://www.marketwatch.com/press-release/ventricular-assist-devices-market-size-opportunity-analysis-and-industry-forecast-by-2024-gmi-analysis-2019-09-04

It is quite evident from the aforementioned trends that the global Ventricular Assist Devices market is well positioned to accumulate sizable gains over 2019-2025. Powered by the escalating prevalence of CVDs worldwide and the robust technological advancements in healthcare, the overall Ventricular Assist Devices industry size is liable to be pegged at USD 3.5 billion by 2025.
Related Reports:

Neonatal Infant Care Market: https://www.marketwatch.com/press-release/neonatal-infant-care-market-2019-opportunity-analysis-and-industry-forecast-by-2025-2020-01-13

Sports Medicine Market: https://www.marketwatch.com/press-release/sports-medicine-market-2019-analysis-growth-by-top-companies-trends-by-types-and-application-forecast-to-2025-2020-01-14

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com/

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ventricular Assist Devices Market 2019 Demand, Size, Growth Research Report by 2025 here

News-ID: 1896165 • Views:

More Releases from Global Market Insight, Inc

Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Halocarbon Products
Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Ha …
Global inhalation anesthesia market is poised to gain massive momentum over the forecast period of 2019 to 2025. This can be credited to the significant rise in product adoption primarily driven by increasing surgical procedures related to respiratory, neurological and chronic disorders. Additionally, supportive reimbursement scenario across developed countries and availability of several insurance schemes for quick and affordable surgical procedures will increase the application of inhalational anesthetics, thereby supporting
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, Cigna, Highmark, HCSC
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, C …
Regular occurrences of long-term diseases will bolster the health insurance industry trends in the next few years. This rise can be attributed to the changing dietary habits, lack of physical activities, poor nutrition, excessive alcohol use, and tobacco consumption. Various Government-backed initiatives by several programs like State Children's Health Insurance Program, Medicaid, Life programs, Department of Defense, TRICARE are employed to provide health insurance policies. Centers for Medicare & Medicaid
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG India Limited
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG Ind …
The global ambulance services market is estimated to foresee momentous growth through the forthcoming time period owing to an upsurge in road accidents. Additionally, the growing prevalence of chronic diseases and increasing medical tourism trend is further slated to augment the overall market size through 2026. Additionally, the introduction of new ambulance models and launch of new technologies that focus on the enhancement of ambulatory care is likely to proliferate
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Coherus BioSciences
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, …
Touted to be an intrinsic sub-vertical of healthcare and medical devices industry, biosimilars market is poised to record phenomenal gains in the upcoming years owing to the fact that these play a pivotal role in augmenting public health issue by addressing the customer needs to a much larger extent. Numerous reports suggest that biosimilars would result in overall potential savings of nearly USD 100 billion by the end of 2020,

All 5 Releases


More Releases for Ventricular

Ventricular Assist Device Market Report Up tp 2031
Visiongain has published a new report on Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. GlobalVentricular Assist Device market was valued at US$ xx billion in 2020 and is projected to reach at a market value of
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Global Ventricular Fibrillation Market 2021- Analysis and Trends
“Global Ventricular Fibrillation Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. Ventricular fibrillation is a heart rhythm problem that occurs when the heart beats with rapid, erratic electrical impulses. This causes pumping chambers in your heart (the ventricles) to quiver uselessly, instead of pumping blood. Together, all four chambers pump blood to and from the body. When the atria, the two upper chambers, contract at an excessively high
05-08-2017 | Health & Medicine
SA-BRC
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major
Ventricular Assist Device Market: Global Markets & Advanced Technologies
North America Ventricular Assist Device Market: Overview Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts